AMEX · DRAY
Public company research
$11.56
Down-$0.39 (-3.33%)
Updated Oct 14, 2026, 10:42 PM
SID Score
2.3/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance · DRAY
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 13, 2026
DRAY closed at $11.56 after 21 trading sessions, down 19.25% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 13, 2026 | $11.5158 | $11.60 | $11.44 | $11.56 | 3.36K |
| Oct 12, 2026 | $11.41 | $11.55 | $11.34 | $11.52 | 14.9K |
| Oct 9, 2026 | $11.611 | $11.611 | $11.395 | $11.49 | 3.86K |
| Oct 8, 2026 | $11.03 | $11.61 | $11.03 | $11.61 | 15.01K |
| Oct 7, 2026 | $11.37 | $11.37 | $11.251 | $11.28 | 5.57K |
| Oct 6, 2026 | $11.68 | $11.77 | $11.50 | $11.5688 | 11.89K |
| Oct 5, 2026 | $11.13 | $11.72 | $11.13 | $11.51 | 15.35K |
| Oct 2, 2026 | $11.2807 | $11.46 | $10.9063 | $10.9063 | 5.11K |
| Oct 1, 2026 | $11.17 | $11.3579 | $10.94 | $11.3579 | 7.23K |
| Sep 30, 2026 | $11.59 | $11.6344 | $11.2707 | $11.2707 | 8.74K |
| Sep 29, 2026 | $12.27 | $12.34 | $11.6232 | $11.6232 | 17.97K |
| Sep 28, 2026 | $12.6499 | $12.6499 | $12.3907 | $12.3907 | 10.71K |
| Sep 25, 2026 | $12.38 | $12.90 | $12.05 | $12.86 | 21.22K |
| Sep 24, 2026 | $12.48 | $12.56 | $12.18 | $12.50 | 4.56K |
| Sep 23, 2026 | $12.82 | $12.82 | $12.39 | $12.5632 | 9.64K |
| Sep 22, 2026 | $13.18 | $13.50 | $12.83 | $12.83 | 14.29K |
| Sep 21, 2026 | $12.83 | $13.03 | $12.83 | $12.9225 | 7.86K |
| Sep 18, 2026 | $13.11 | $13.3099 | $12.77 | $12.77 | 19.65K |
| Sep 17, 2026 | $13.88 | $13.98 | $13.201 | $13.246 | 7.48K |
| Sep 16, 2026 | $14.105 | $14.30 | $13.99 | $14.1985 | 6.45K |
| Sep 15, 2026 | $14.35 | $14.45 | $14.3157 | $14.3157 | 5.29K |
The latest Smart Investors Daily articles mentioning DRAY.
Company
Market Activity
Research & News
DRAY research
Company profile and research snapshot.
DRAY aims to generate monthly income while providing exposure to the price returns of DraftKings Inc. (DKNG) stock, subject to a cap on potential gains. The fund utilizes a synthetic covered call strategy via standardized exchange-traded and FLEX options, which consists of three elements: i) synthetic long exposure, ii) covered call writing, and iii) US Treasurys for collateral. The synthetic long exposure seeks to replicate the price movements of DKNG by purchasing and selling at-the-money calls and puts that have one- to six-month terms. To generate income, the fund writes call options with an expiration of one month or less and a strike price of approximately 0%-15% above DKNG's current share price. This limits participation in potential gains if DKNG shares increase in value. The short put positions fully expose investors to the downside of the stock. Note: the fund does not invest directly in DKNG stocks. Thus, investors are not entitled to any DKNG dividends.
Consensus and target data currently published for this company.
No generated briefing is available yet.
globenewswire.com · Dec 10, 2025
CHICAGO and MILWAUKEE and NEW YORK, Dec. 10, 2025 (GLOBE NEWSWIRE) -- YieldMax® ETFs today announced distributions for the YieldMax® Group 2 weekly pay ETFs. Group 2 Distribution Announcement Ex.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning DRAY.
